06.02.2019
96
Mascola, M.D., an internationally recognized expert on HIV vaccine development, has been named the new director of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In this role, he will lead a. Vaccine Clinical Studies Safeguards The Vaccine Research Center (VRC) Clinical Trials Core is devoted to the tenets of Good Clinical Practices (GCP) and the primary charge to the physician of doing no harm. 
The Vaccine Research Center (VRC) Clinical Trials Core is devoted to the tenets of Good Clinical Practices (GCP) and the primary charge to the physician of doing no harm. Thus, the VRC has established multiple safeguards to protect volunteers from physical and social harm. There is a systematic commitment to the ethical principles of clinical studies.
The Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases.
Established by former President Bill Clinton as part of an initiative to develop an AIDS vaccine, the VRC is a unique venture within the NIH intramural research program. Initially spearheaded by NIAID, the National Cancer Institute, and the NIH Office of AIDS Research, the VRC is now part of the NIAID organization. The mission of the Vaccine Research Center (VRC) is to conduct research that facilitates the development of effective vaccines for human disease.
The primary focus of research include: • • •.